Chemical Compound

Simvastatin dimer

CAS Registry Number 476305-24-5
Simvastatin dimer chemical structure
Primary Record

Simvastatin dimer

In stock
8,658 g
Purity
98.9 %
CAS
476305-24-5

Compound Identifiers & Properties

CAS
476305-24-5
PubChem CID
46782920
SMILES
CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)OC(=O)C[C@@H](C[C@@H](CC[C@H]4[C@H](C=CC5=C[C@@H](C[C@@H]([C@H]45)OC(=O)C(C)(C)CC)C)C)O)O)C
Canonical SMILES
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]3CC(=O)O[C@H](CC[C@@H]4[C@@H]5C(=C[C@H](C)C[C@@H]5OC(=O)C(C)(C)CC)C=C[C@@H]4C)C3)[C@H]21

Names & Synonyms

  • Simvastatin dimer
  • Simvastatin Dimer Impurity
  • Simvastatindimer
  • Simvastatin EP Impurity D
  • Simvastatin Impurity D
  • 476305-24-5
  • SimvastatinDimerImpurity
  • UNII-0OC7Z384H2
  • RefChem:183136
  • 0OC7Z384H2
  • DTXSID60197228
  • Simvastatin specified impurity D
  • Simvastatin specified impurity D [EP]
  • CTK8E7516
  • DTXCID70119719
  • Simvastatin USP Related Compound D
  • EINECS 225-303-7
  • C50H76O10
  • AKOS027326650
  • Simvastatin dimer, 98% - 1MG 1mg
  • ZINC257373097
  • IS27834
  • SIMVASTATIN IMPURITY D [EP IMPURITY]
  • Simvastatin impurity, simvastatin dimer- [USP]
  • RT-015703
  • SIMVASTATIN IMPURITY D (EP IMPURITY)
  • J2.377.031H
  • Simvastatin impurity, simvastatin dimer-(USP)
  • Simvastatin impurity, simvastatin dimer-[USP]
  • Q27237034
  • B2694-263916
  • [(2R,4R)-2-[2-[(1S,2S,6R,8S,8aR)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl]-6-oxooxan-4-yl] (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
  • SIMVASTATIN IMPURITY, SIMVASTATIN DIMER- [USP IMPURITY]
  • SIMVASTATIN IMPURITY, SIMVASTATIN DIMER-(USP IMPURITY)
  • SIMVASTATIN IMPURITY, SIMVASTATIN DIMER-[USP IMPURITY]
  • (2R,4R)-2-(2-{(1S,2S,6R,8S,8aR)-8-[(2,2-Dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}ethyl)-6-oxooxan-4-yl (3R,5R)-7-{(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}-3,5-dihydroxyheptanoate
  • (2R,4R)-2-{2-[(1S,2S,6R,8S,8AR)-8-[(2,2-DIMETHYLBUTANOYL)OXY]-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL]ETHYL}-6-OXOOXAN-4-YL (3R,5R)-7-[(1S,2S,6R,8S,8AR)-8-[(2,2-DIMETHYLBUTANOYL)OXY]-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL]-3,5-DIHYDROXYHEPTANOATE
  • (3R,5R)-(2R,4R)-2-(2-((1S,2S,6R,8S,8aR)-8-((2,2-dimethylbutanoyl)oxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)ethyl)-6-oxotetrahydro-2H-pyran-4-yl 7-((1S,2S,6R,8S,8aR)-8-((2,2-dimethylbutanoyl)oxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoate
  • 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-ss,d-dihydroxy-2,6-dimethyl-, (2R,4R)-2-[2-[(1S,2S,6R,8S,8aR)-8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-2,6-dimethyl-1-naphthalenyl]ethyl]tetrahydro-6-oxo-2H-pyran-4-yl ester, (ssR,dR,1S,2S,6R,8S,8aR)-; Simvastatin Impurity D
  • 2,2-Dimethylbutyric acid (1S)-3beta,7alpha-dimethyl-8alpha-[2-[[(2R,4R)-4-[[(3R,5R)-3,5-dihydroxy-7-[(1S)-1-(2,2-dimethylbutyryloxy)-3beta,7alpha-dimethyl-1,2,3,7,8,8aalpha-hexahydronaphthalene-8alpha-yl]heptanoyl]oxy]-6-oxotetrahydro-2H-pyran]-2-yl]ethyl]-1,2,3,7,8,8aalpha-hexahydronaphthalene-1beta-yl ester